Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Inosine pranobex [BAN:JAN]
RN: 36703-88-5
UNII: W1SO0V223F
InChIKey: YLDCUKJMEKGGFI-QCSRICIXSA-N

Note

  • An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.

Molecular Formulas

  • C10-H12-N4-O5.3C9-H9-N-O3.3C5-H13-N-O
  • C10-H12-N4-O5.C14-H22-N2-O4

Molecular Weight

  • 1115.24
 

Classification Codes

  • Adjuvants, Immunologic
  • Anti-Infective Agents
  • Antiretroviral
  • Antiviral
  • Antiviral Agents
  • Immunologic Factors
  • Immunomodulator
  • Immunostimulant
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Inosine pranobex
  • Inosine pranobex [BAN:JAN]

MeSH Heading

  • Inosine pranobex

Synonyms

  • Aviral
  • Delimmun
  • EINECS 253-162-1
  • Imunovir
  • Inosine pranobex
  • Inosiplex
  • INPX
  • Isoprinosin
  • Isoprinosina
  • Isoprinosine
  • Isoviral
  • Methisoprinol
  • NP 113
  • NTP 10381
  • UNII-W1SO0V223F
  • Viruxan

Systematic Names

  • Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3)
  • Inosine, compound with (2-hydroxypropyl)dimethylammonium p-acetamidobenzoate (1:3)
  • Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3)

Registry Numbers

CAS Registry Number

  • 36703-88-5

FDA UNII

  • W1SO0V223F

System Generated Number

  • 0036703885

Molecular Formulas

Molecular Formulas

  • C10-H12-N4-O5.3C9-H9-N-O3.3C5-H13-N-O
  • C10-H12-N4-O5.C14-H22-N2-O4

Molecular Formula Fragments

  • C10-H12-N4-O5
  • C14-H22-N2-O4
  • C5-H13-N-O
  • C9-H9-N-O3
  • COMPONENT

Structure Descriptors

InChI

1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1

InChIKey

YLDCUKJMEKGGFI-QCSRICIXSA-N

Smiles

n1(c2c(nc1)c([nH]cn2)=O)[C@@H]1O[C@H](CO)[C@H]([C@H]1O)O.c1(ccc(C(O)=O)cc1)NC(C)=O.C(N(C)C)[C@@H](C)O.c1(ccc(C(O)=O)cc1)NC(C)=O.c1(ccc(C(O)=O)cc1)NC(C)=O.C([C@@H](C)O)N(C)C.C([C@@H](C)O)N(C)C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 2300mg/kg (2300mg/kg)   Drugs in Japan Vol. -, Pg. 124, 1990.
mouse LD50 intravenous 1570mg/kg (1570mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.
mouse LD50 oral 9410mg/kg (9410mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.
mouse LD50 subcutaneous 2960mg/kg (2960mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.
rat LD50 intraperitoneal 2960mg/kg (2960mg/kg)   Drugs in Japan Vol. -, Pg. 124, 1990.
rat LD50 intravenous 1970mg/kg (1970mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.
rat LD50 oral 9150mg/kg (9150mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.
rat LD50 subcutaneous 3460mg/kg (3460mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988.